Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed No phase listed Observational Results available

Reveal LINQ for Chronic Obstructive Pulmonary Disease (COPD)

ClinicalTrials.gov ID: NCT04169529

Public ClinicalTrials.gov record NCT04169529. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 8, 2026, 1:18 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of the LINQ™ for COPD study is to characterize Reveal LINQ™ derived data from patients with COPD by assessing the relationship between changes in LINQ™ derived data with COPD exacerbation events.

Study identification

NCT ID
NCT04169529
Recruitment status
Completed
Study type
Observational
Phase
Not listed
Enrollment
42 participants

Conditions and interventions

Eligibility (public fields only)

Age range
45 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 24, 2020
Primary completion
Jun 26, 2023
Completion
Jun 26, 2023
Last update posted
Oct 25, 2024

2020 – 2023

United States locations

U.S. sites
9
U.S. states
7
U.S. cities
9
Facility City State ZIP Site status
Bay Area Cardiology Associates Brandon Florida 33511
Baptist Medical Center Jacksonville Florida 32207
Clinical Site Partners Inc Leesburg Florida 34748
Memorial Health University Medical Center Savannah Georgia 31404
Virtua Pulmonology Marlton Marlton New Jersey 08053
Northwell Health Lenox Hill Hospital New York New York 10075
The Ohio State University Columbus Ohio 43210
Oklahoma Cardiovascular Research Group Oklahoma City Oklahoma 73120
Lancaster General Hospital Lancaster Pennsylvania 17604

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04169529, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 25, 2024 · Synced Sep 8, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04169529 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →